Northwest & Ethical Investments’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
Northwest & Ethical Investments's NVO Position: Q4 2017 in Review
Northwest & Ethical Investments sold out of Novo Nordisk (NVO) in Q4 2017, closing a stake of 50,730 shares — an estimated $1.22M sold.
Northwest & Ethical Investments first reported a position in NVO in Q1 2017 and held it in 3 quarters. The position peaked at $2.99M in Q2 2017. 552 funds tracked by Wall St. Rank hold NVO as of Q4 2017.
- Northwest & Ethical Investments reported no remaining Novo Nordisk position as of Q4 2017 after selling out during the quarter.
- Northwest & Ethical Investments sold 50,730 Novo Nordisk shares in Q4 2017, an estimated $1.22M.
- Northwest & Ethical Investments first reported a position in Novo Nordisk in Q1 2017 and held it in 3 quarters.
- Northwest & Ethical Investments's Novo Nordisk position peaked at $2.99M in Q2 2017.
- 552 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2017.
Based on Northwest & Ethical Investments's 13F filing for Q4 2017, filed 8 Jul 2025.